Skip to main content
. 2015 Jun 8;10(6):e0129012. doi: 10.1371/journal.pone.0129012

Table 1. Association of clinicopathological parameters and PODXL expression by polyclonal antibody HPA 2110.

Non-membranous Membranous
n(%) 93 (56.0) 73 (44.0) p-value
Age, years
<65 46 (49.5) 36 (49.3) 1.000
≥65 47 (50.5) 37 (50.7)
Gender
Male 52 (55.9) 40 (54.8) 1.000
Female 41 (44.1) 33 (45.2)
T
1 10 (11.0) 2 (2.7) 0.045
2 25 (27.5) 18 (24.7)
3 54 (59.3) 50 (68.5)
4 2 (2.2) 3 (4.1)
Missing 2
N
0 26 (28.6) 23 (31.5) 0.733
1 65 (71.4) 50 (68.5)
Missing 2
M
0 88 (95.7) 69 (95.8) 1.000
1 4 (4.3) 3 (4.2)
Missing 1 1
Stage (WHO)
IA 7 (7.9) 2 (2.8) 0.606
IB 9 (10.1) 9 (12.3)
IIA 10 (11.2) 10 (13.7)
IIB 58 (65.2) 46 (63.0)
III 0 (0.0) 3 (4.1)
IV 5 (5.6) 3 (4.1)
Missing 4
Lymph node ratio
<20% 68 (75.6) 56 (77.8) 0.852
≥20% 22 (24.4) 16 (22.2)
Missing 3 1
Grade
1 17 (21.2) 7 (11.1) 0.103
2 53 (66.3) 44 (69.8)
3 10 (12.5) 12 (19.1)
Missing 13 10
Perineural invasion
Yes 51 (67.1) 57 (87.7) 0.005
No 25 (22.9) 8 (12.3)
Missing 17 8
Perivascular invasion
Yes 23 (30.7) 26 (43.3) 0.151
No 52 (69.3) 34 (56.7)
Missing 18 13

Fischer exact-test was used for 2x2 tables and linear-by-linear association test for tables with more than two rows. Missing data excluded from the analyses.